Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Gene Bridges, the recombineering company, has announced that Genencor International USA, a part of Danisco US, has completed a commercial license agreement for the use of the Red/ET recombination technology from Gene Bridges.
Subscribe to our email newsletter
Under the terms of the agreement, Gene Bridges has licensed the Red/ET technology to Genencor for the purpose of genetically engineering recombinant micro-organisms for use in industrial applications.
Red/ET is said to be a revolutionary method for DNA engineering. Recombineering with Red/ET allows unlimited cloning, subcloning, and modification of DNA at any chosen position. It permits precise engineering of DNA molecules of any size, including very large ones such as BACs or the E.coli chromosome. According to the company, Red/ET Recombineering is one simple and powerful tool to modify plasmids, BACs, and even E.coli chromosomes.
Gary Stevens, CEO of Gene Bridges, said: “We are very pleased to add Danisco to the list of major industrial biotechnology companies using Red/ET. Recombineering is the technology of choice in DNA engineering and is used worldwide in industry and academia.”